Sequoia and Greenoaks lead massive $5BN Series C funding round in Isomorphic Labs
AI-generated summary Isomorphic Labs has raised a Series C funding round co-led by Greenoaks and Sequoia to leverage artificial intelligence for drug discovery and a new generation of medicines. The company states that the funds will support artificial intelligence advancement and clinical development infrastructure as it moves drug candidates toward clinical trials.